CTOs on the Move

Care Providers Of Minnesota

www.careproviders.org

 
Care Providers Of Minnesota is a Minneapolis, MN-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
  • Number of Employees: 25-100
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

General Healthcare Resources

General Healthcare Resources is a Plymouth Meeting, PA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Genetic Alliance

Genetic Alliance is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Le-Vel

Premium Level: Premium Lifestyle Founded in 2012 by Jason Camper and Paul Gravette, Le-Vel formulates and sells nutritional/health and wellness products like the Le-Vel Thrive product line. Le-Vel is the only health and wellness company that uses cloud-based technology for its day-to-day business operations. Le-Vel`s cloud-based infrastructure enables the company to keep overhead to a minimum while increasing commissions and opportunities for its independent Brand Promoters and putting more money into the Le-Vel THRIVE product line. Some of the products in the Le-Vel line include: Thrive Premium Lifestyle DFT (Derma Fusion Technology), Thrive Premium Lifestyle Capsules, Thrive Premium Lifestyle Mix, Activate, Boost, Balance, Black Label, Café, DFT Duo, Expand, FORM, Thrive Kids, Move, Thrive PRO, Rest, Pure, BURN, THRIVEFIT and Thrive Bites. Le-Vel and the Le-Vel Thrive brand have more than 10 million customers and brand promoters. The company ships within the United States, Canada, Australia, New Zealand, the United Kingdom, and Mexico. In less than 7 years in business, Le-Vel reached $2 billion in lifetime sales.

OKC-County Health Department

The OKC-County Health Department serves the residents of Oklahoma County by promoting and protecting health, preventing disease, and creating partnerships.

Xagenic

Xagenic is a molecular diagnostics company developing a true point- of-care platform. Our aim is to enable on-demand, near patient molecular testing, empowering clinicians in making treatment decisions for their patients at the time of first consultation. This will dramatically improve patient care and reduce health care costs.